Financials
Financial year 2024
MavSAN Med from Willebroek, company number BE0797148671, closed financial year 2024 with a result of € 25,731 after tax. For that financial year MavSAN Med recorded a gross margin of € 45,858 and equity of € 31,624. Compared with financial year 2023, the result moved from € 33,393 to € 25,731. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 31, 2025.
€ 31,624
▲ 51% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 25,731
▼ 23% vs 2023
Profit after tax over the fiscal year.
€ 37,855
▼ 18% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 15,000 paid out
58 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
€ 16,339
Of which on lease € 3,972.
Debts at end 2024
€ 13,069
▼ 23% vs 2023
€ 4,136 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 1,437
▲ € 1,299 vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 20,183
▲ 68% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Gross margin | € 46,127 | € 45,858 | ▼ 1% |
| Profit after taxes | € 33,393 | € 25,731 | ▼ 23% |
| Equity | € 20,893 | € 31,624 | ▲ 51% |
| Total debts | € 44,177 | € 49,689 | ▲ 12% |
| Cash | € 46,119 | € 37,855 | ▼ 18% |
| Retained profit | € 18,393 | € 29,124 | ▲ 58% |
| Dividend | € 15,000 | € 15,000 | |
| Bank debt | € 17,000 | € 13,069 | ▼ 23% |
| Balance sheet total | € 65,070 | € 81,313 | ▲ 25% |
Key figures of MavSAN Med, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to MavSAN Med?
What happened at MavSAN Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 25,731 (▼ 23% vs 2023). filed late Source: NBB ↗
- Raïssa Ineza Ngabe became a director. NBB
- New establishment in Willebroek. KBO
- Santos Mavutukidi became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 33,393 profit in 2023 to € 25,731 profit in 2024.
Paid € 20,183 in corporate taxes since 2023.
Best year ever: 2023, with € 33,393 profit.
Paid out € 30,000 in dividends to the owners in total.
A new publication or filing at MavSAN Med? We notify you, reason included.
Follow MavSAN MedDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MavSAN Med are Raïssa Ineza Ngabe and Santos Mavutukidi .
Directors
According to the 2024 annual accounts
Raïssa Ineza Ngabe
Director
since 2024
Santos Mavutukidi
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Jozef De Blockstraat 12
2830 Willebroek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0797.148.671
- VAT number
- BE 0797.148.671
- Registered office
- Jozef De Blockstraat 12, 2830 Willebroek
- Names & denominations
- MavSAN Med
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 January 2023
- Peppol
- Active · Active since 4 Sept 2025